Literature DB >> 30158145

The reliability of thromboelastography in a simulated rotary wing environment.

Robert Scott1, Brian Burns1, Sandra Ware1, Floris Oud1, Matthew Miller1,2.   

Abstract

BACKGROUND: With the increasing role of point-of-care coagulation testing in trauma, we sought to test the reliability of the thromboelastography (TEG)6s machine in a simulated rotary wing environment.
METHOD: A two-arm study was conducted, running TEG6s quality control cartridges in a helicopter flight simulator with realistic vibration and in stable ground conditions. The flight conditions during testing included take-offs, landings and inflight emergencies such as engine failures. TEG values for R time, K time, α-angle and maximum amplitude (MA) were collected and compared with manufacturers' normal ranges.
RESULTS: 148 TEG samples were included for analysis (72 simulator arm, 76 ground arm). In the simulator arm, four of our K time values fell below the normal range and four MA values were above the normal range. All other values in both simulator and ground arms were in the normal range.
CONCLUSION: The TEG6s is a viable technology in the simulated rotary wing environment, and it is feasible to conduct further studies using human blood in live rotary wing conditions. Extreme flight conditions should be avoided during further testing. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  prehospital care, helicopter retrieval; trauma

Mesh:

Year:  2018        PMID: 30158145     DOI: 10.1136/emermed-2017-207418

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  6 in total

1.  Evaluation of the altitude impact on a point-of-care thromboelastography analyzer measurement: prerequisites for use in airborne medical evacuation courses.

Authors:  Matthieu Boyé; Jacqueline Boissin; Chrystelle Poyat; Pierre Pasquier; Christophe Martinaud
Journal:  Eur J Trauma Emerg Surg       Date:  2020-06-24       Impact factor: 3.693

2.  Assessing TEG6S reliability between devices and across multiple time points: A prospective thromboelastography validation study.

Authors:  Patryck Lloyd-Donald; Leonid Churilov; Brandon Cheong; Rinaldo Bellomo; Peter R McCall; Johan Mårtensson; Neil Glassford; Laurence Weinberg
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

3.  A comparison between the TEG 6s and TEG 5000 analyzers to assess coagulation in trauma patients.

Authors:  Matthew D Neal; Ernest E Moore; Mark Walsh; Scott Thomas; Rachael A Callcut; Lucy Z Kornblith; Martin Schreiber; Akpofure Peter Ekeh; Adam J Singer; Lawrence Lottenberg; Michael Foreman; Susan Evans; Robert D Winfield; Michael D Goodman; Carl Freeman; David Milia; Noelle Saillant; Jan Hartmann; Hardean E Achneck
Journal:  J Trauma Acute Care Surg       Date:  2020-02       Impact factor: 3.697

Review 4.  Hemostatic Testing in Critically Ill Infants and Children.

Authors:  Alison B Nair; Robert I Parker
Journal:  Front Pediatr       Date:  2021-01-08       Impact factor: 3.418

5.  Operability of a Resonance-Based Viscoelastic Haemostatic Analyzer in the High-Vibration Environment of Air Medical Transport.

Authors:  Johannes Zipperle; Bernhard Ziegler; Herbert Schöchl; Wolfgang Voelckel; Christoph J Schlimp; Daniel Oberladstätter
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

Review 6.  Hemorrhagic Resuscitation Guided by Viscoelastography in Far-Forward Combat and Austere Civilian Environments: Goal-Directed Whole-Blood and Blood-Component Therapy Far from the Trauma Center.

Authors:  James H Lantry; Phillip Mason; Matthew G Logsdon; Connor M Bunch; Ethan E Peck; Ernest E Moore; Hunter B Moore; Matthew D Neal; Scott G Thomas; Rashid Z Khan; Laura Gillespie; Charles Florance; Josh Korzan; Fletcher R Preuss; Dan Mason; Tarek Saleh; Mathew K Marsee; Stefani Vande Lune; Qamarnisa Ayoub; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.